Crossref
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
One Health & Risk Management · 2020
DOI: 10.38045/ohrm.2020.1.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift One Health & Risk Management, 2020. Verfasst von Irina RUSU und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
RUSU, I., HODOROGEA, L., & HOLBAN, T. (2020). The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management. https://doi.org/10.38045/ohrm.2020.1.02
Vancouver
RUSU I, HODOROGEA L, HOLBAN T. The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management. 2020. doi:10.38045/ohrm.2020.1.02
BibTeX
@article{RUSU2020,
author = {RUSU, Irina and HODOROGEA, Liliana and HOLBAN, Tiberiu},
title = {The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C},
journal = {One Health & Risk Management},
year = {2020},
doi = {10.38045/ohrm.2020.1.02}
}
EUVIMED